High remission in refractory FL
An oral small-molecule dual PI3Kα/δ inhibitor achieving high response rates in follicular lymphoma patients who have failed at least two prior lines of therapy, offering a new option for refractory cases.
Wang, Huaqing · Feng, Jifeng · Liu, Yanyan · Qian, Zhengzi · Gao, Da · Ran, Xuehong · Zhou, Hui · Liu, Lihong · Fang, Meiyun · Zhou, Hebing · Huang, Zhenqian · Tao, Shi · Chen, Zhuowen · Su, Liping · Su, Hang · Yang, Yu · Xie, Xiaobao · Wu, Huijing · Sun, Ping · Hu, Guoyu · Liang, Aibin · Li, Zhiming
Signal Transduction and Targeted Therapy 2024